UK Pharmaceutical Research to be honoured

Fourteen entries will be vying for the prestigious 2006 UK Prix Galien Award it was announced today. The entries are:

• Alvesco - Altana Pharma (Respiratory)
• Alimta - Eli Lilly and Company (Oncology)
• Myozyme - Genzyme Speciality Therapeutics (Metabolic disorders)
• Rotarix - GlaxoSmithKline (Gastroenterology)
• Erbitux - Merck Pharmaceuticals (Oncology)
• Moviprep - Norgine (Gastroenterology)
• Movicol Paediatric (Gastroenterology)
• Xolair - Novartis (Respiratory)
• Aromasin - Pfizer (Oncology)
• Lyrica - Pfizer (Neurology)
• Avastin - Roche (Oncology)
• Tarceva - Roche (Oncology)
• Zevalin - Schering Healthcare (Oncology)
• Protelos - Servier Laboratories (Endocrine system)

The award recognises outstanding achievement in pharmaceutical research and development, and is presented to the most innovative treatment to have been recently developed in the UK.

The independent judging committee members currently range from experts within the National Institute of Clinical Excellence (NICE) and the Scottish Medicines Consortium (SMC) through to leading medical consultants, academics and a media doctor.

When deciding upon the winners they have been asked to identify the medicines that have made the most significant contribution to patient care in the UK. They also judge against broader themes such as efficacy, safety, benefits and innovation.

The overall winning entry will receive the gold Prix Galien medal. Previous winners of this highly prestigious honour are Herceptin, Prevenar and Viagra.

The Awards ceremony will be held at the Houses of Parliament on 26 September 2006.

For further details, or to arrange an interview with Prix Galien judges Professor Sir Michael Rawlins (NICE) or Professor Parveen Kumar (BMA) please contact Sarah Beyrath at Right Angle Learning: Sarah.Beyrath@ralearning.com. Ph: 020 8834 1039 or 07958672239

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Dr Vasumathy Sivarajasingam explains why screening for domestic abuse should be standard...

PCNs opt out of phase 2 of COVID-19 vaccination programme over workload pressure

PCNs opt out of phase 2 of COVID-19 vaccination programme over workload pressure

Some PCNs have opted out of phase 2 of the COVID-19 vaccination programme, with others...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

The risk of cerebral venous thrombosis (CVT) following COVID-19 infection is eight...

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

Retired Derbyshire GP Dr Om Prakash Chawla, who was known for his warmth and kindness,...

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

General practice can build on changes to care during the COVID-19 pandemic to strengthen...